VERA - Vera Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VERA is currently covered by 7 analysts with an average price target of $48.1. This is a potential upside of $27.24 (130.58%) from yesterday's end of day stock price of $20.86.

Vera Therapeutics's activity chart (see below) currently has 21 price targets and 44 ratings on display. The stock rating distribution of VERA is 13.79% HOLD and 86.21% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.39% with an average time for these price targets to be met of 141 days.

Highest price target for VERA is $100, Lowest price target is $26, average price target is $60.86.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 07-May-2025. First documented stock forecast 08-Jun-2021.

Currently out of the existing stock ratings of VERA, 4 are a HOLD (13.79%), 25 are a BUY (86.21%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$26

$3.26 (14.34%)

$38

1 months 13 days ago
(07-May-2025)

8/8 (100%)

$3.38 (14.94%)

169

Buy

$100

$77.26 (339.75%)

$107

1 months 13 days ago
(07-May-2025)

0/5 (0%)

$77.38 (342.09%)

Buy

$71

$48.26 (212.23%)

$75

3 months 16 days ago
(04-Mar-2025)

5/11 (45.45%)

$42.59 (149.91%)

271

Buy

$61

$38.26 (168.25%)

$64

3 months 24 days ago
(27-Feb-2025)

1/5 (20%)

$31.59 (107.41%)

163

Buy

$75

$52.26 (229.82%)

$20

7 months 23 days ago
(28-Oct-2024)

3/4 (75%)

$27.66 (58.43%)

252

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VERA (Vera Therapeutics) average time for price targets to be met?

On average it took 141 days on average for the stock forecasts to be realized with a an average price target met ratio 63.39

Which analyst has the current highest performing score on VERA (Vera Therapeutics) with a proven track record?

LIISA BAYKO

Which analyst has the current lower performing score on VERA (Vera Therapeutics) with a proven track record?

VAMIL DIVAN

Which analyst has the most public recommendations on VERA (Vera Therapeutics)?

Liisa Bayko works at EVERCORE and has 6 price targets and 4 ratings on VERA

Which analyst is the currently most bullish on VERA (Vera Therapeutics)?

Pete Stavropoulos with highest potential upside - $77.26

Which analyst is the currently most reserved on VERA (Vera Therapeutics)?

Maury Raycroft with lowest potential downside - -$21.46

Vera Therapeutics in the News

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., April 09, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on April 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 211,250 shares of Class A common stock and restricted stock units (RSUs) for 105,125 shares of Class A common stock to sixteen...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?